Physician profile
Christina M Nguyen
NPI 1508186701
$32,380.84
in general payments reported to CMS, 2019-2025
71 companies · $5,731 in 2025
The $5,731 reported for 2025 was more than what a typical Neuromuscular Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $530).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,404 · 2020: $3,373 · 2021: $4,578 · 2022: $4,627 · 2023: $4,998 · 2024: $5,669 · 2025: $5,731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Travel and Lodging: $240 · Education: $78.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16,079.13 |
| Travel and Lodging | $240.26 |
| Education | $78.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,842.98 | 2019-2025 | |
| Ucb, INC. | $1,948.66 | 2019-2025 | Briviact, Rystiggo, Nayzilam |
| Acadia Pharmaceuticals INC | $1,588.39 | 2019-2025 | Nuplazid, Daybue |
| Novartis Pharmaceuticals Corporation | $1,561.55 | 2019-2025 | |
| Neurocrine Biosciences, INC. | $1,523.64 | 2019-2025 | Ingrezza |
| Biogen, INC. | $1,332.55 | 2019-2025 | Vumerity, Avonex, Tysabri |
| Mdd US Operations, LLC | $1,326.41 | 2022-2025 | Gocovri, Gocovri, Qelbree |
| Ipsen Biopharmaceuticals, INC | $1,232.41 | 2019-2025 | Dysport |
| Sk Life Science, INC. | $1,163.11 | 2020-2025 | |
| Amneal Pharmaceuticals LLC | $1,103.51 | 2019-2025 | Crexont, Rytary |
| Teva Pharmaceuticals USA, INC. | $1,100.86 | 2019-2025 | Austedo Xr, Austedo, Austedo Xr |
| Merz Pharmaceuticals, LLC | $1,096.91 | 2021-2025 | Xeomin, Inbrija |
| Eisai INC. | $918.94 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $913.07 | 2019-2025 | Ultomiris |
| Sunovion Pharmaceuticals INC. | $847.15 | 2019-2022 |
Show all 71 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.